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TECHNICAL NOTE
Antibodies against macrophages that overlap in specificity
with fibroblasts
TSUTOMU INOUE, DAVID PLIETH, CHRISTO D. VENKOV, CAROL XU, and ERIC G. NEILSON
Department of Medicine and Department of Cell and Developmental Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt
University School of Medicine, Nashville, Tennessee
Antibodies against macrophages that overlap in specificity with
fibroblasts.
Background. Fibroblasts can be misidentified as macro-
phages because both cell types share antigens that are as-
sociated with popular antibodies targeting the monocyte/
macrophage lineage. With the recent description of fibroblast-
specific protein 1 (FSP1), we revisited the specificity of
antibodies directed against macrophages to determine system-
atically which antibodies best distinguish both cell types in fi-
brotic tissues.
Methods. Tissue fibrosis was produced in mice carrying the
GFP transgene encoding green fluorescent protein under the
control of the FSP1 promoter. Single cell suspensions from these
marked tissues were submitted for flow cytometry using anti-
bodies against Mac-1, Mac-2, Mac-3, F4/80, CD68, major histo-
compatibility complex (MHC) class II, and CD45, and cDNA
amplification of mRNA encoding the above target antigens was
performed using specific primer sets in sorted pools of cells. Fi-
brotic tissues were also stained by immunohistochemistry with
the same antibodies and examined under confocal microscopy.
Results. Comparison overlap between FSP1+ fibroblasts with
each of the macrophage markers demonstrated that all anti-
macrophage antibodies (Mac-1, Mac-2, Mac-3, CD68, MHC
class II, and CD45) except one (F4/80) recognize both cell types.
Conclusion. Antibodies directed against F4/80 clearly distin-
guish macrophages from FSP1+ fibroblasts in fibrotic tissues
and is the preferred antibody in mice.
Macrophages and fibroblasts frequently appear to-
gether in fibrotic tissue following inflammation. A num-
ber of antibodies are available to identify monocytes or
macrophages, although their specificity for fibroblasts has
not been studied systematically. Until the characteriza-
tion of fibroblast-specific protein 1 (FSP1) a few years
ago [1], fibroblasts were bereft of specific markers. FSP1,
also known as S100A4, is only expressed in fibroblasts [1–
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3], in epithelia undergoing epithelial-mesenchymal tran-
sition (EMT) to form fibroblasts [3, 4] or in metastatic tu-
mor cells [5]. Although FSP1+ fibroblasts in fibrotic tissue
typically express vimentin and HSP47, or occasionally a-
smooth muscle actin (a-SMA) [6], none of these proteins
are specific for fibroblasts. Primary mesenchymal cells
also do not express FSP1, since the gene encoding FSP1
is only active after embryonic day (E) 8.5 in the mouse
[1]. FSP1 is expressed during murine development only
in fibroblasts derived from secondary epithelium follow-
ing EMT [3], or briefly in very early granulocytic lineages
from the bone marrow that disappears quickly with mat-
uration (unpublished observations). About 12% of tissue
fibroblasts come from the blood stream after they are re-
leased by the bone marrow [4]. FSP1+ fibroblasts from
bone marrow and peripheral blood are Mac-1+ and Gr-
1low−negative in preliminary data using flow cytometry with
a lineage panel including Mac-1, Gr-1, B220, CD3, and
TER119 (data not shown). The present study was under-
taken because of concern that fibroblasts might be regu-
larly misidentified as monocytes or macrophages if care
is not taken in choosing a reliable cell-specific marker.
METHODS
Transgenic mice and the fibrosis model of unilateral
ureteral obstruction (UUO)
Three-month-old BALB/c FSP1.GFP (green fluores-
cent protein) transgenic mice and GFP− littermates were
used in all experiments. FSP1.GFP transgenic mice ex-
press GFP in fibroblasts under the control of the FSP1
promoter [5]. UUOs were created in single kidneys and
harvested at 21 days as previously described [7]. Insti-
tutional Animal Care and Use Committee at Vanderbilt
University approved all animal studies.
Flow cytometry
Three weeks after operation, anesthetized mice were
systemically perfused with 50 mL ice-cold phosphate
buffered saline (PBS) before the kidneys were removed.
Diced tissue specimens were incubated for 30 minutes
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Fig. 1. Flow cytometric analysis of single cell suspensions from fibrotic kidneys. After gating on live cells by forward and side scatter (A), both
macrophage and fibroblast populations were separately gated based on F4/80 staining and green fluorescent protein (GFP) expression under the
control of the fibroblast-specific protein 1 (FSP1) promoter (B), F4/80+ staining represented 3.6% of the fibroblast population. Mac is macrophage-
red, Fib is fibroblast-green (C). Each macrophage marker staining was then compared between FSP1+ fibroblasts (D to I) and F4/80-defined
macrophages (J to O). Representative histograms are shown with an average and standard deviation from five individual experiments. Broken lines
indicate negative controls.
at room temperature with gentle stirring in Dul-
becco’s modified Eagle’s medium (DMEM), including
0.1% collagenase (Sigma Chemical Co., St. Louis, MO,
USA), 0.001% hyaluronidase (Sigma Chemical Co.), and
0.002% DNase (Sigma Chemical Co.) [3]. Cells were then
fixed in PBS containing 4% paraformaldehyde, then in-
cubated with 0.1% Tween-20 for 15 minutes at 37◦C [3,
8]. An Avidin/Biotin Blocking Kit (Vector Laboratories,
Burlingame, CA, USA) plus antimouse CD16/CD32 (Fc
blocker) (BD Bioscience, San Jose, CA, USA) were em-
ployed before incubation with all primary antibodies.
Cells were stained using optimum concentrations of pri-
mary antibody for 20 minutes at 4◦C in PBS contain-
ing 1% fetal bovine serum (FBS) and 0.002% saponin.
At least, 1 × 104 cells per sample were analyzed in the
Vanderbilt Flow Cytometry Core (FACSCalibur) (BD
Bioscience). Mac-1 (M1/70), Mac-3 (M3/84), major his-
tocompatibility complex (MHC) class II (M5/114.15.2),
and CD45 (30-F11) were obtained from BD Bioscience;
F4/80 (Cl:A3-1) and CD68 (FA-11) were obtained from
Serotec Inc. (Raleigh, NC, USA); and Mac-2 (M3/38) was
from Cedarlane Laboratories (Ontario, Canada). For bi-
otinylated antibodies, streptavidin-dye (BD Bioscience)
was employed. Isotype-specific antibodies were used as
negative controls.
Tissue immunostaining
Paraffin embedded kidney sections were de-
parafinized, rehydrated, and then incubated with
0.05% trypsin and 10 lg/mL proteinase K in Hepes
buffer saline for 15 minutes at room temperature [3].
Sections were next exposed to Fc blocker (see above)
and washed in blocking buffer [PBS with 1.0% bovine
serum albumin (BSA)]. Primary antibodies were diluted
in blocking buffer and then applied for 1 hour. A tyra-
mide signal amplification kit (Molecular Probes, Eugene,
OR, USA) was used to heighten the reaction product.
A laser scanning confocal microscope (LSM510-Meta)
(Carl Zeiss, Thornwood, NY, USA) in the Vanderbilt
Cell Imaging Core was used to capture digital images
Fig. 3. Cell sorting for analysis of mRNA encoding fibroblast-specific protein 1 (FSP1) and macrophage markers. Using the same gates for the flow
cytometric analysis shown in Figure 1 (A), cells were sorted into several pools: FSP1+ fibroblasts [green fluorescent protein (GFP+)] (B), and the
remaining GFP− cells into Mac-1+ and Mac-1− groups (C). Data shown in (C) is representative of the previous staining pattern with macrophage
antibodies. Three pools of cells were sorted for reverse transcription-polymerase chain reaction (RT-PCR) analysis: FSP1+ fibroblasts (GFP+)
(D), macrophage-enriched (Mac-1+/GFP−) (E), and macrophage/fibroblast-depleted (Mac-1−/GFP−) (F). mRNA from unsorted cells was used
for negative control without reverse transcriptase (RT) (G).
for assembly and editing in Photoshop (Adobe Systems,
Inc., San Jose, CA, USA).
Reverse transcriptase-polymerase chain
reaction (RT-PCR)
Nonfixed, nonpermeabilized cells were incubated with
antimouse CD16/CD32 Fc blocker, and stained by Mac-1
antibody in PBS containing 1% FBS for 20 minutes at
4◦C. The cells were then sorted into PBS with 1% FBS
based on GFP and Mac-1 using the Vanderbilt Flow Cy-
tometry Core (FACSAria) (BD Bioscience). Total RNA
was isolated using RNeasy Mini Kit (Qiagen, Valencia,
CA, USA). RNA concentrations were adjusted based
on cell number. RQ1 RNase-Free DNase (Promega,
Madison, WI, USA) and iScript cDNA Synthesis Kit
(Bio-Rad, Hercules, CA, USA) were used for DNA
digestion and reverse transcription [3]. All reactions ran
on the following cycler schedule: 95◦C 5 minutes, then
95◦C 1 minute, 58◦C 1 minute, 72◦C 1 minute for 25 to 35
cycles (midlinear range) with a finish at 72◦C for 7min-
utes. Amplicons were separated in 2% agarose gel and
stained by ethidium bromide. The following primers were
used: FSP1 [3] forward 5′-GTGATTTGGGTCATGCT
CAG-3′, reverse 5′-CATTGCACATCATGGCAATG-
3′; Mac-1 [9] forward 5′-CAGATCAACAATGTGACC
GTATGG-3′, reverse 5′-CATCATGTCCTTGTACTG
CCGC-3′; Mac-2 [10] forward 5′-GCCCCGCATGCT
GATCACAATC-3′, reverse 5′-GTTGTACTGCAGTA
GGTGAGCATCGT-3′; CD68 [11] forward 5′-CTTCC
CACAGGCAGCACAG-3′, reverse 5′-AATGATGAG
AGGCAGCAAGAGG-3′; F4/80 [11] forward 5′-CTT
TGGCTATGGGCTTCCAGTC-3′, reverse 5′-GCAAG
GAGGACAGAGTTTATCGTG-3′; MHC class II [12]
forward 5′-GGCTCCTCAAGCGACTGTGT-3′, reverse
5′-GGGGCTGGAATCTCAGGTTC-3′; CD45 [13] for-
ward 5′-GAGACCAGGAAGTCTGTGCTCAGTA-3′,
reverse 5′-CGCAGAACCATTGGCAGCATGTTCT-
3′; procollagen, type I [14] forward 5′-GCATGGCCA
AGAAGACATCC-3′, reverse 5′-CCTCGGGTTTCC
ACGTCTC-3′; and glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) [14] forward 5′-GCACAGTCA
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Fig. 2. Immunostaining of fibrotic tissues.
Stainings revealed that F4/80 localized to
green fluorescent protein (GFP−) [fibroblast-
specific protein 1 (FSP1−)] cells (A, B, and
C, arrows). Mac-2–stained cytoplasm of both
GFP+ (FSP1+) fibroblasts (D, E, and F, ar-
rows) and GFP− (FSP1−) cells; also, many
tubular epithelial cells were positive (D, E,
and F, ∗). Major histocompatibility complex
(MHC) class II staining was in a cell mem-
brane pattern in both GFP+ fibroblasts (G,
H, and I, arrows) and GFP− cells. Tubular
epithelial staining of MHC class II was sim-
ilar to interstitial cell staining in our experi-
ments. Many inflammatory cells were stained
by CD45, which also costained FSP1+ (GFP+)
fibroblasts (J, K, and L, arrows). Bar = 25 lm.
Results are summarized on the table (M). Re-
sults are indicated by + (positive), +/− (weak
positive), or − (negative).
AGGCCGAGAAT-3′, reverse 5′-GCCTTCTCCATGG
TGGTGAA-3′.
RESULTS AND DISCUSSION
Various studies using antibodies of overlapping speci-
ficity have given mixed messages regarding the expres-
sion of FSP1 in monocytes, macrophages, lymphocytes,
and in some cell lines [1, 15–19]. No systematic com-
parison of antibodies with specificity for macrophages
has been made with marked fibroblasts harvested from
fibrotic tissues. Here, we used transgenic mice carry-
ing the GFP gene under the control of the FSP1 pro-
moter to properly mark fibroblasts; the high selectivity
of FSP1 in fibroblasts has been previously established
[1–3, 7]. UUO following surgical ligation produces an
acute nephropathy associated with significant infiltra-
tion by macrophages and lymphocytes leading to fibrosis
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and eventual loss of the kidney [3, 7]. Cells suspensions
were prepared from fibrotic kidney tissues or from con-
tralateral control kidneys. Macrophage gates were estab-
lished using highly specific antisera against F4/80; F4/80
does not stain established fibroblast cell lines in culture
[20].
In Figure 1, all antibodies against monocytes/
macrophages, except F4/80, stained both populations of
cells. The staining intensities for Mac-1, Mac-3, CD68,
CD45, and MHC class II were often higher in mono-
cytes/macrophages than in fibroblasts. The staining with
Mac-2 was also cross-reactive but with less intensity in
fibroblasts. CD68 also stained only one third of fibrob-
lasts, and those reactions were relatively faint. F4/80 was
largely nonoverlapping (<3%) with FSP1+ fibroblasts,
which is within the error of normal experimental varia-
tion [20].
Immunohistochemistry was employed to ascertain the
distribution of cellular staining in fibrotic tissue because
tubular epithelial cells are also reported to be Mac-2
and/or Mac-3 positive in normal adult kidney [21]. More-
over, CD45 and MHC class II are expressed by many
leukocytes, including macrophages, in inflammatory or
pathologic tissues [22]. Representative stainings for a few
of the markers are shown in Figure 2. Overall, the re-
sults of our immunohistochemistry were consistent with
findings from flow cytometry, and Mac-3 showed ap-
proximately the same distribution as Mac-2 (data not
shown). F4/80 again was largely nonoverlapping (<3%)
with FSP1+ fibroblasts. Of special interest was the appar-
ent coexpression of the CD45 common leukocyte antigen
in FSP1+ fibroblasts.
Finally, in Figure 3A and B, whole cell suspensions
from fibrotic kidneys were sorted by flow cytome-
try into the following three pools: FSP1+ fibroblasts
(GFP+), macrophage-enriched (Mac-1+ and GFP−), or
macrophage/fibroblast-depleted (Mac-1− and GFP−).
Mac-1 was used as the second marker for cell sorting
because Mac-1 is a surface antigen while F4/80 is dis-
tributed in both cytoplasm and cell membrane. Each pool
was then subjected to cDNA amplification to determine
the selective presence of mRNA encoding the various
macrophage markers used for flow cytometry in Figure 1
(Fig. 3D to F). Except for mRNA encoding F4/80 being
absent in GFP+ (FSP1+) fibroblast pool and mRNA en-
coding FSP1being absent in the Mac-1+/GFP− and Mac-
1−/GFP− pools, the mRNA encoding our other test set
of macrophage markers were present in all pools of cells
except control. mRNA encoding CD45 was found in all
cell pools, including fibroblasts (Fig. 3D). Although CD45
is expressed by all hematopoietic lineages [23], it is also
found in fibrocytes from peripheral blood [24], and in our
hands is also expressed by FSP1+ fibroblasts in tissue.
Thus, CD45 does not discriminate between macrophages
and fibroblasts, either.
This distribution of amplicons confirmed the selectivity
of F4/80 as the clearest marker of macrophages. Approx-
imately 70% of the cells in the Mac-1+/GFP− group were
F4/80+ (Fig. 3C), confirming that Mac-1 is also present in
other nonfibroblast cells besides macrophages [21]. We
suspect the remaining 30% is made up of granulocytes
and dendritic cells. Furthermore, mRNA transcripts en-
coding type I collagen were coexpressed with FSP1 in
GFP+ fibroblasts. Mac-1− leucocytes, tubular epithelia,
mesangial cells, podocytes, or cells from blood vessels
in the Mac-1−/GFP− pool also express mRNA encod-
ing nonselective macrophage markers as well as type I
collagen, as expected.
F4/80 is well-known as a highly restricted macrophage
molecule in mice [20]. Anti-CD68 antibody has been
extensively used to characterize monocytes/macrophage
populations in humans. CD68 is also known as
macrosialin, a murine homologue [25]. Although these
two antibodies distinguish macrophages from fibrob-
lasts, F4/80 is a substantially better macrophage marker
than CD68 for mice in terms of specificity and intensity
of expression. Mac-2 antigen, galectin-3, was originally
described as carbohydrate-binding protein 35 (CBP35)
in 3T3 fibroblasts [26]. It is also highly expressed in
thioglycollate-elicited peritoneal macrophages [27]. Fi-
nally, around 70% of FSP1+ fibroblasts are Mac-1+ and
unlike the other markers, levels of Mac-1 expression are
similar in both fibroblasts and macrophages.
CONCLUSION
We demonstrate the Mac-series of antibodies are
overlapping while F4/80 best distinguishes mono-
cytes/macrophages from FSP1+ fibroblasts, and is the pre-
ferred linage marker for macrophages.
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